Epilepsy Drug ‘Cenobamate’ Nears Korea Launch…Dong-A ST applies for approval
The domestic introduction of SK Biopharmaceuticals’ epilepsy drug ‘Cenobamate’ (marketed as ‘Xcopri’ in the U.S.) is underway. Cenobamate,…
Dong-A ST
1 개의 기사가 있습니다.